Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03218683
Title Study of AZD5991 in Relapsed or Refractory Haematologic Malignancies.
Recruitment Suspended
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications

chronic lymphocytic leukemia/small lymphocytic lymphoma

multiple myeloma

peripheral T-cell lymphoma

non-Hodgkin lymphoma

Richter's syndrome

Therapies

AZD5991

Age Groups:
Covered Countries USA

Facility Status City State Zip Country Details
Research Site Orange California 92868 United States Details
Research Site Aurora Colorado 80045 United States Details
Research Site Atlanta Georgia 30322 United States Details
Research Site Boston Massachusetts 02215 United States Details
Research Site Saint Louis Missouri 63110 United States Details
Research Site New York New York 10065 United States Details
Research Site Columbus Ohio 43210 United States Details
Research Site Portland Oregon 97239 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field